Anixa Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ANIX Nasdaq 2836 www.anixa.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anixa Biosciences, Inc.

Anixa Biosciences (ANIX) Upgraded to Strong Buy: Here's What You Should Know - Jul 22nd, 2026 10:00 am
Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year? - Jul 22nd, 2026 7:40 am
New Strong Buy Stocks for July 22nd - Jul 22nd, 2026 5:15 am
Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date - Jul 6th, 2026 6:30 am
Anixa Biosciences secures Korean patent for breast cancer vaccine - Jun 30th, 2026 4:31 am
Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040 - Jun 29th, 2026 6:45 am
Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium - Jun 26th, 2026 7:10 am
Here's Why You Should Add ANIX Stock to Your Portfolio Now - Jun 25th, 2026 8:30 am
Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium - Jun 11th, 2026 7:05 am
Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance - Jun 1st, 2026 7:00 am
/C O R R E C T I O N -- Anixa Biosciences, Inc./ - May 11th, 2026 9:48 am
Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV - May 1st, 2026 7:15 am
Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology - Apr 29th, 2026 7:10 am
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting - Apr 22nd, 2026 6:45 am
Replays from RedChip's Biotech Investor Conference Now Available - Apr 20th, 2026 9:00 am
Anixa Biosciences Highlights Lean Cash Burn, CAR-T Survival Signals, and Phase II Vaccine Plan at Conference - Apr 14th, 2026 8:02 pm
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation - Apr 10th, 2026 10:55 am
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026 - Apr 9th, 2026 7:05 am
Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026 - Apr 7th, 2026 6:55 am
Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs - Apr 6th, 2026 7:10 am